Related Experiment Video
Updated: Jul 16, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative
Velizar Shivarov1,2, Gergana Tsvetkova3, Ilina Micheva4
1Department of Experimental Research, Medical University Pleven, 5800 Pleven, Bulgaria.
This study explores the link between NKG2D receptor ligands (MICA/MICB) and CALR-mutated myeloproliferative neoplasms (MPN). Specific MICA and KLRK1 gene variants were associated with increased MPN risk, suggesting an immunogenetic role.
Area of Science:
- Immunogenetics
- Molecular Biology
- Hematology
Background:
- Immune surveillance influences myeloproliferative neoplasm (MPN) development.
- The role of the NKG2D receptor and its ligands (MICA/MICB) in CALR-mutated MPN is not well understood.
Purpose of the Study:
- To investigate the association between MICA/MICB genetic variants and CALR-mutated MPN.
- To explore the expression of MICA/MICB in CALR-mutated MPN cells.
Main Methods:
- Genotyping of MICA and MICB in CALR-mutated MPN patients and controls using next-generation sequencing.
- Analysis of KLRK1 (NKG2D) polymorphisms and haplotype associations.
- Molecular dynamics simulations and reanalysis of transcriptomic data (scRNA-seq, RNA-seq).
Main Results:
- The MICA*004:001 allele was significantly associated with CALR-mutated MPN.
- A specific KLRK1 haplotype (G-A-G-T) increased CALR-mutated MPN risk (OR = 3.61).
- CALR-mutant cells showed higher MICA/MICB transcript expression.
Conclusions:
- An immunogenetic and transcriptomic link between the NKG2D-MICA/MICB axis and CALR-mutated MPN is suggested.
- Further protein-level and functional studies are needed to confirm mechanistic and therapeutic implications.
More Related Videos
10:21Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Abnormal Proliferation